Hepregen Corporation
Latest round
- Series A
Last raised
- Jun 2008
Total raised
- $3M
Investors
- 1
About Hepregen Corporation
Founded in 2007 and headquartered in Medford, US, Hepregen Corporation focuses on developing liver cell culture systems for drug testing.Hepregen Corporation offers a range of cell-based technology solutions primarily designed for pharmaceutical companies. Their products include liver cell culture systems that enhance drug testing processes, aiming to optimize drug safety and efficacy.The company generates revenue through the sale of its liver cell culture technology, providing various services to pharmaceutical companies that require high-quality testing systems.5 mn to accelerate the development of new liver cell culture products aimed at enhancing drug testing capabilities. The company is exploring expansion into European and Asian markets by 2025, intending to broaden its customer base and improve access to its innovative solutions for pharmaceutical research.
Who invested in Hepregen Corporation
1 investor across 1 round
See all investors in Hepregen Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2008
Amount
$3M
Investors
Questions about Hepregen Corporation
Who invested in Hepregen Corporation?
Hepregen Corporation has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hepregen Corporation raised?
Hepregen Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Hepregen Corporation last raise money?
Hepregen Corporation's most recent round on record is a Series A, in Jun 2008.
What does Hepregen Corporation do?
Founded in 2007 and headquartered in Medford, US, Hepregen Corporation focuses on developing liver cell culture systems for drug testing.
Where is Hepregen Corporation headquartered?
Hepregen Corporation is headquartered in Medford, US.
Which VCs invest in companies like Hepregen Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Hepregen Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Hepregen Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.